×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
PR Newswire
SPY001, an anti-α4β7 antibody engineered for infrequent, subcutaneous dosing successfully completed a 28-day GLP toxicity study and remains...
2 weeks ago
Spyre Therapeutics Announces $180 Million Private Placement
PR Newswire
PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ: SYRE), a biotechnology company advancing a pipeline of...
2 months ago
Spyre Therapeutics Announces Grants of Inducement Awards | | news-journal.com
Longview News-Journal
WALTHAM, Mass., May 3, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage...
3 weeks ago
Spyre Therapeutics Expands Portfolio and Strengthens Leadership - TipRanks.com
Tipranks
The latest update is out from Spyre Therapeutics (SYRE). Spyre Therapeutics, Inc. has secured a significant deal with Paragon Therapeutics, granting them...
2 weeks ago
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Rating of “Buy” by Analysts
Defense World
Read Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Rating of “Buy” by Analysts at Defense World.
1 week ago
Rebranded Spyre Therapeutics Secures $180M to Advance IBD Antibody Pipeline
BioSpace
The private placement from existing and new investors extends the company's cash runway into the second half of 2026 and will help take two...
5 months ago
Spyre Therapeutics (SYRE) Price Target Increased by 5.00% to 42.84
MSN
The average one-year price target for Spyre Therapeutics (NasdaqGS:SYRE) has been revised to 42.84 / share. This is an increase of 5.00% from the prior...
1 week ago
Spyre Therapeutics (NASDAQ:SYRE) Stock Price Down 5.5%
MarketBeat
Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) shares dropped 5.5% during mid-day trading on Thursday . The company traded as low...
4 days ago
Spyre Therapeutics Secures $180M in Strategic Financial Move - TipRanks.com
Tipranks
An update from Spyre Therapeutics (SYRE) is now available. Spyre Therapeutics, Inc. has announced a significant move in the financial markets,...
2 months ago
Spyre Therapeutics (NASDAQ:SYRE) Earns Outperform Rating from Analysts at Robert W. Baird
Defense World
Read Spyre Therapeutics (NASDAQ:SYRE) Earns Outperform Rating from Analysts at Robert W. Baird at Defense World.
3 weeks ago